Pfizer Vaccine Cleared in U.S., a Landmark in Covid-19 Fight
- Built from new technology, shot was developed in just months
- Authorization sets the stage for vast immunization effort
This article is for subscribers only.
Pfizer Inc. gained emergency U.S. authorization for its Covid-19 vaccine on Friday, completing an unprecedented scientific sprint that could eventually help bring an end to a pandemic that has killed nearly 300,000 Americans.
The Food and Drug Administration’s decision to authorize use of Pfizer and partner BioNTech SE’s vaccine will now set in motion a complicated immunization drive that will launch across the country in coming days.